Trade PTN stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Palatin Technologies, Inc. (PTN) is trading at US$10.86, up 4.12% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$17.24M. Over the past 52 weeks, PTN has traded between US$5.61 and US$31.00. On Syfe you can trade PTN with $0 commission and add it to your watchlist.
| Previous close | US$10.43 |
|---|---|
| Market cap | US$17.24M |
| 52-week range | US$5.61 – US$31.00 |
| Volume | 50.77K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Palatin Technologies, Inc.
Palatin Technologies, Inc. is a biopharmaceutical company, which engages in the development of medicines based on molecules that modulate the activity of the melanocortin receptor system. Its primary product candidate is marketed under the Vyleesi brand, the trade name for bremelanotide, which is used for the treatment of premenopausal women with acquired, generalized, hypoactive sexual desire disorder (HSDD). The company was founded by Carl Spana and John K. A. Prendergast on November 21, 1986 and is headquartered in Princeton, NJ.
Year: 1993
Palatin Technologies to Transfer Listing to Nasdaq
May 18, 9:35 PM · MT Newswires
Palatin Technologies, Inc. (PTN) stock is trading at US$10.86, +4.12% from the previous close of US$10.43.
The market cap for Palatin Technologies, Inc. (PTN) stock is approximately US$17.24M.
The 52-week high for Palatin Technologies, Inc. (PTN) stock is US$31.00.
The 52-week low for Palatin Technologies, Inc. (PTN) stock is US$5.61.
Palatin Technologies, Inc. (PTN) does not currently pay a dividend.
Stay on top of PTN
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
